151 related articles for article (PubMed ID: 9894977)
1. Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia.
Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Baethmann A; Reulen HJ
Neurosurgery; 1999 Jan; 44(1):163-71; discussion 171-2. PubMed ID: 9894977
[TBL] [Abstract][Full Text] [Related]
2. Monotherapy with dextromethorphan or tirilazad--but not a combination of both--improves outcome after transient focal cerebral ischemia in rats.
Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Baethmann A; Reulen HJ
Exp Brain Res; 1998 Sep; 122(1):121-7. PubMed ID: 9772119
[TBL] [Abstract][Full Text] [Related]
3. Combination drug therapy and mild hypothermia: a promising treatment strategy for reversible, focal cerebral ischemia.
Schmid-Elsaesser R; Hungerhuber E; Zausinger S; Baethmann A; Reulen HJ
Stroke; 1999 Sep; 30(9):1891-9. PubMed ID: 10471442
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection in transient focal cerebral ischemia by combination drug therapy and mild hypothermia: comparison with customary therapeutic regimen.
Zausinger S; Westermaier T; Plesnila N; Steiger HJ; Schmid-Elsaesser R
Stroke; 2003 Jun; 34(6):1526-32. PubMed ID: 12730554
[TBL] [Abstract][Full Text] [Related]
5. Combination drug therapy and mild hypothermia after transient focal cerebral ischemia in rats.
Zausinger S; Schöller K; Plesnila N; Schmid-Elsaesser R
Stroke; 2003 Sep; 34(9):2246-51. PubMed ID: 12893947
[TBL] [Abstract][Full Text] [Related]
6. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats.
Xue D; Slivka A; Buchan AM
Stroke; 1992 Jun; 23(6):894-9. PubMed ID: 1595111
[TBL] [Abstract][Full Text] [Related]
7. Effect of tirilazad mesylate given after permanent middle cerebral artery occlusion in rat.
Hellström HO; Wanhainen A; Valtysson J; Persson L; Hillered L
Acta Neurochir (Wien); 1994; 129(3-4):188-92. PubMed ID: 7847162
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia.
Schmid-Elsaesser R; Hungerhuber E; Zausinger S; Baethmann A; Reulen HJ
Brain Res; 1999 Jan; 816(2):471-9. PubMed ID: 9878871
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection in ischemic stroke--combination drug therapy and mild hypothermia in a rat model of permanent focal cerebral ischemia.
Schöller K; Zausinger S; Baethmann A; Schmid-Elsaesser R
Brain Res; 2004 Oct; 1023(2):272-8. PubMed ID: 15374753
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective efficacy of intra-arterial and intravenous magnesium sulfate in a rat model of transient focal cerebral ischemia.
Westermaier T; Hungerhuber E; Zausinger S; Baethmann A; Schmid-Elsaesser R
Acta Neurochir (Wien); 2003 May; 145(5):393-9; discussion 399. PubMed ID: 12820046
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats.
Onal MZ; Li F; Tatlisumak T; Locke KW; Sandage BW; Fisher M
Stroke; 1997 May; 28(5):1060-5. PubMed ID: 9158650
[TBL] [Abstract][Full Text] [Related]
12. Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats.
Westermaier T; Zausinger S; Baethmann A; Schmid-Elsaesser R
Acta Neurochir (Wien); 2005 May; 147(5):525-32; discussion 532. PubMed ID: 15838594
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of the novel brain-penetrating antioxidant U-101033E and the spin-trapping agent alpha-phenyl-N-tert-butyl nitrone (PBN).
Schmid-Elsaesser R; Hungerhuber E; Zausinger S; Baethmann A; Reulen HJ
Exp Brain Res; 2000 Jan; 130(1):60-6. PubMed ID: 10638441
[TBL] [Abstract][Full Text] [Related]
14. Tirilazad widens the therapeutic window for riluzole-induced attenuation of progressive cortical degeneration in an infant rat model of the shaken baby syndrome.
Smith SL; Hall ED
J Neurotrauma; 1998 Sep; 15(9):707-19. PubMed ID: 9753218
[TBL] [Abstract][Full Text] [Related]
15. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke.
Savitz SI; Erhardt JA; Anthony JV; Gupta G; Li X; Barone FC; Rosenbaum DM
J Cereb Blood Flow Metab; 2000 Aug; 20(8):1197-204. PubMed ID: 10950380
[TBL] [Abstract][Full Text] [Related]
16. Infarct tolerance against temporary focal ischemia following spreading depression in rat brain.
Yanamoto H; Hashimoto N; Nagata I; Kikuchi H
Brain Res; 1998 Feb; 784(1-2):239-49. PubMed ID: 9518633
[TBL] [Abstract][Full Text] [Related]
17. Effects of the 21-amino steroid tirilazad mesylate (U-74006F) on brain damage and edema after perinatal hypoxia-ischemia in the rat.
Bågenholm R; Andiné P; Hagberg H
Pediatr Res; 1996 Sep; 40(3):399-403. PubMed ID: 8865275
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion.
Kawaguchi K; Graham SH
Brain Res; 1997 Feb; 749(1):131-4. PubMed ID: 9070637
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies.
Liu Y; Belayev L; Zhao W; Busto R; Belayev A; Ginsberg MD
Eur J Pharmacol; 2001 Oct; 428(2):193-201. PubMed ID: 11675036
[TBL] [Abstract][Full Text] [Related]
20. Superior neuroprotective efficacy of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia.
Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Plesnila N; Baethmann A; Reulen HJ
Stroke; 1997 Oct; 28(10):2018-24. PubMed ID: 9341713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
